Approval · Notice of Compliance 20044 · 2017
TREMFYA: Notice of Compliance 20044
Issued November 10, 2017
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 20044
- Date
- November 10, 2017
- Company
- Janssen Inc.Toronto, Ontario, Canada
- Product type
- Biologic
- Submission
- New Drug Submission (NDS)
- Submission class
- New Active Substance (NAS)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| TREMFYA | 02469758 | Marketed |
Medicinal ingredients
- GUSELKUMAB 100 MG per ML